| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.58M | 31.96M | 37.84M | 54.41M | 96.82M | 30.77M |
| Gross Profit | 15.74M | 16.57M | 23.39M | 40.88M | 88.71M | 26.71M |
| EBITDA | 8.45M | 36.27M | -179.52M | -52.65M | 87.01M | 35.38M |
| Net Income | 25.08M | 27.95M | -189.81M | -51.75M | 88.89M | 17.88M |
Balance Sheet | ||||||
| Total Assets | 593.89M | 624.91M | 657.87M | 872.86M | 1.14B | 1.02B |
| Cash, Cash Equivalents and Short-Term Investments | 30.29M | 71.33M | 28.63M | 41.43M | 24.83M | 81.57M |
| Total Debt | 150.21M | 175.54M | 231.91M | 232.95M | 403.56M | 344.27M |
| Total Liabilities | 171.10M | 198.82M | 256.79M | 264.18M | 448.09M | 412.86M |
| Stockholders Equity | 422.78M | 426.09M | 401.07M | 608.67M | 687.04M | 608.16M |
Cash Flow | ||||||
| Free Cash Flow | -3.89M | 1.10M | 11.66M | 219.00K | 2.96M | 3.85M |
| Operating Cash Flow | -3.85M | 1.44M | 12.27M | 767.00K | 3.03M | 4.00M |
| Investing Cash Flow | 13.91M | 105.98M | -20.70M | 192.25M | -174.37M | 99.62M |
| Financing Cash Flow | -45.90M | -59.55M | -19.53M | -185.58M | 45.70M | -23.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £1.51B | 4.93 | 12.27% | 5.71% | 4.80% | 37.75% | |
76 Outperform | £50.18M | 3.28 | 6.10% | 3.92% | -6.10% | 889.93% | |
68 Neutral | £347.01M | 8.24 | 5.35% | 5.88% | -6.52% | -20.26% | |
67 Neutral | £1.22B | 7.07 | 10.25% | 3.62% | -8.66% | 553.35% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
51 Neutral | £150.60M | -6.51 | -9.62% | ― | ― | ― | |
50 Neutral | £217.97M | 35.14 | 5.91% | 2.71% | -14.09% | ― |